• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯卡西姆地区高危心血管疾病患者中糖化血红蛋白(HbA1c)升高与致动脉粥样硬化血脂谱的关联。

Linking elevated HbA1c with atherogenic lipid profile among high risk cardiovascular patients at Qassim, Saudi Arabia.

作者信息

Akasha Rihab, Ahmad Saheem, Abdeen Rnada, Abulgasim Sara, Barnawi Heba, Elhussein Nagwan, Hussien A Rehab, Alshammari Dina Nawaf, Elafandy Nancy, Alouffi Sultan

机构信息

Department of Clinical Laboratory Sciences,College of Applied Medical Sciences,University of Hail, Saudi Arabia.

出版信息

Bioinformation. 2024 Mar 31;20(3):212-216. doi: 10.6026/973206300200212. eCollection 2024.

DOI:10.6026/973206300200212
PMID:38711997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11069612/
Abstract

The relationship between glycated hemoglobin (HbA1c) and an atherogenic lipid profile which is associated with a higher risk of cardiovascular disease is of interest. A retrospective cross-sectional study was conducted on 83 participants aged between 14 and 77 years. Their venous blood was drawn to determine the HbA1c and fasting lipid profile including total cholesterol triglycerides and high-density lipoprotein cholesterol (HDL-C) low-density lipoprotein cholesterol (LDL-C) non-HDL cholesterol and the LDL/HDL ratio were also calculated. The correlations between HbA1c levels and these lipid profile parameters were analyzed. The study showed a significant correlation between HbA1c and LDL-C non-HDL-C and the LDL/HDL ratio. Although there was no significant difference in total cholesterol levels among all groups the levels of total cholesterol and HbA1c were positively correlated. HDL-C exhibited direct correlations with HbA1c there was no correlation between HbA1c and clinical characteristics except for age. Data shows that HbA1c can be used as a predictor of dyslipidemia in diabetic patients there is a significant correlation between HbA1c and an atherogenic lipid profile which highlights the importance of glycemic control in reducing the risk of cardiovascular disease.

摘要

糖化血红蛋白(HbA1c)与具有致动脉粥样硬化作用的血脂谱之间的关系备受关注,这种血脂谱与心血管疾病风险较高相关。对83名年龄在14至77岁之间的参与者进行了一项回顾性横断面研究。采集他们的静脉血以测定HbA1c和空腹血脂谱,包括总胆固醇、甘油三酯、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、非高密度脂蛋白胆固醇,并计算LDL/HDL比值。分析了HbA1c水平与这些血脂谱参数之间的相关性。研究表明,HbA1c与LDL-C、非HDL-C以及LDL/HDL比值之间存在显著相关性。尽管所有组的总胆固醇水平无显著差异,但总胆固醇水平与HbA1c呈正相关。HDL-C与HbA1c呈直接相关性,除年龄外,HbA1c与临床特征之间无相关性。数据表明,HbA1c可作为糖尿病患者血脂异常的预测指标,HbA1c与具有致动脉粥样硬化作用的血脂谱之间存在显著相关性,这突出了血糖控制在降低心血管疾病风险方面的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aa9/11069612/27d0939259e4/973206300200212F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aa9/11069612/6379661f1c2c/973206300200212F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aa9/11069612/27d0939259e4/973206300200212F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aa9/11069612/6379661f1c2c/973206300200212F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aa9/11069612/27d0939259e4/973206300200212F2.jpg

相似文献

1
Linking elevated HbA1c with atherogenic lipid profile among high risk cardiovascular patients at Qassim, Saudi Arabia.沙特阿拉伯卡西姆地区高危心血管疾病患者中糖化血红蛋白(HbA1c)升高与致动脉粥样硬化血脂谱的关联。
Bioinformation. 2024 Mar 31;20(3):212-216. doi: 10.6026/973206300200212. eCollection 2024.
2
Lipoprotein Ratios: Correlation With Glycated Hemoglobin (HbA1c) Among Thyroid Disorders' Patients.脂蛋白比率:甲状腺疾病患者与糖化血红蛋白(HbA1c)的相关性
Cureus. 2024 Feb 14;16(2):e54191. doi: 10.7759/cureus.54191. eCollection 2024 Feb.
3
High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.高水平的个体血脂谱和血脂比值作为2型糖尿病血糖控制不佳的预测指标。
Vasc Health Risk Manag. 2019 Jun 5;15:149-157. doi: 10.2147/VHRM.S209830. eCollection 2019.
4
The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape.糖尿病血脂异常患者中血脂异常及致动脉粥样硬化指数与血糖控制的关联:真实世界情况
Cureus. 2023 Sep 26;15(9):e45985. doi: 10.7759/cureus.45985. eCollection 2023 Sep.
5
Lipoprotein Ratios: Correlations With Glycated Hemoglobin Among Type 2 Diabetes Mellitus Patients.脂蛋白比率:2型糖尿病患者糖化血红蛋白之间的相关性
Cureus. 2024 Feb 5;16(2):e53665. doi: 10.7759/cureus.53665. eCollection 2024 Feb.
6
Prevalence of dyslipidemia and the relationship between HbA1C and lipid profile in Moroccan patients with T2DM: a cross-sectional study.摩洛哥 2 型糖尿病患者血脂异常的患病率及糖化血红蛋白与血脂谱的关系:一项横断面研究。
Pan Afr Med J. 2022 Oct 19;43:86. doi: 10.11604/pamj.2022.43.86.35898. eCollection 2022.
7
Correlation of HbA1c Level with Lipid Profile in Type 2 Diabetes Mellitus Patients Visiting a Primary Healthcare Center in Jeddah City, Saudi Arabia: A Retrospective Cross-Sectional Study.沙特阿拉伯吉达市一家初级医疗保健中心2型糖尿病患者糖化血红蛋白(HbA1c)水平与血脂谱的相关性:一项回顾性横断面研究
Diseases. 2023 Oct 31;11(4):154. doi: 10.3390/diseases11040154.
8
Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia.阿富汗2型糖尿病患者糖化血红蛋白与血脂谱的相关性:糖化血红蛋白可预测血脂异常。
Ther Adv Endocrinol Metab. 2017 Apr;8(4):51-57. doi: 10.1177/2042018817692296. Epub 2017 Mar 20.
9
Relationship between HbA1c and Lipid Profile Seen in Bangladeshi Type 2 Diabetes Mellitus Patients Attending BIRDEM Hospital: A Cross-Sectional Study.在孟加拉国BIRDEM医院就诊的2型糖尿病患者中观察到的糖化血红蛋白(HbA1c)与血脂谱的关系:一项横断面研究。
Mymensingh Med J. 2019 Jan;28(1):91-95.
10
Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study.三级护理医院中2型糖尿病患者糖化血红蛋白(HbA1c)与血脂谱的相关性:一项回顾性研究。
Diabetes Metab Syndr Obes. 2019 Aug 29;12:1639-1644. doi: 10.2147/DMSO.S222271. eCollection 2019.

本文引用的文献

1
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2017 年全球糖尿病患病率估计数和 2045 年预测值。
Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023. Epub 2018 Feb 26.
2
Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.糖尿病管理中糖化血红蛋白(A1C)之外的指标:血糖达标时间、低血糖及其他参数
Diabetes Technol Ther. 2017 May;19(S2):S16-S26. doi: 10.1089/dia.2017.0029.
3
Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia.
阿富汗2型糖尿病患者糖化血红蛋白与血脂谱的相关性:糖化血红蛋白可预测血脂异常。
Ther Adv Endocrinol Metab. 2017 Apr;8(4):51-57. doi: 10.1177/2042018817692296. Epub 2017 Mar 20.
4
Dyslipidemia in patients with chronic kidney disease: etiology and management.慢性肾脏病患者的血脂异常:病因与管理
Int J Nephrol Renovasc Dis. 2017 Feb 7;10:35-45. doi: 10.2147/IJNRD.S101808. eCollection 2017.
5
Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients.糖化血红蛋白(HbA1c)检测在糖尿病患者诊断及预后中的意义
Biomark Insights. 2016 Jul 3;11:95-104. doi: 10.4137/BMI.S38440. eCollection 2016.
6
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality.低密度脂蛋白胆固醇、治疗策略及其对心血管疾病发病率和死亡率影响的综述。
J Clin Lipidol. 2016 May-Jun;10(3):472-89. doi: 10.1016/j.jacl.2015.11.010. Epub 2015 Nov 25.
7
NLA Task Force on Statin Safety--2014 update.美国国家脂质协会他汀类药物安全性特别工作组——2014年更新版
J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S1-4. doi: 10.1016/j.jacl.2014.03.003.
8
Importance of measuring non-HDL cholesterol in type 2 diabetes patients.测量2型糖尿病患者非高密度脂蛋白胆固醇的重要性。
J Pak Med Assoc. 2014 Feb;64(2):124-8.
9
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study.小而密的低密度脂蛋白胆固醇浓度可预测冠心病风险:动脉粥样硬化风险社区(ARIC)研究。
Arterioscler Thromb Vasc Biol. 2014 May;34(5):1069-77. doi: 10.1161/ATVBAHA.114.303284. Epub 2014 Feb 20.
10
Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study.即使在非糖尿病水平范围内,糖化血红蛋白也是日本普通人群心血管疾病的一个预测指标:久山研究。
Cardiovasc Diabetol. 2013 Nov 7;12:164. doi: 10.1186/1475-2840-12-164.